biotech

Muscadine Grapeseed Supplement on Clinical Trial for CArdiovascular Disease

Filed in archive Drugs, Vaccines and Therapeutics , Food and Agriculture on October 26, 2007

Muscadine Grapeseed Supplement on Clinical Trial for CArdiovascular Disease
Wake Forest University Baptist Medical Center researchers are conducting the first-ever clinical study to evaluate the potential cardiovascular health benefits of muscadine grape seeds. Muscadine is a grapevine species native to southeastern United States, whose highly pigmented, thick skins have been found to contain high polyphenol (resveratrol) content. The researchers will be evaluating the effect of a dietary supplement sold under the label Nature's Pearl on 50 participants with or at high risk for cardiovascular disease.
Nature's Pearl is prepared in a way that generates a high concentration of plant chemicals, including gallic acid, ellagic acid, oligomeric proanthocyanidins (OPCs) and resveratrol. These are known to be antioxidants, or nutrients that can prevent or slow the oxidative damage to the body.
For the first four weeks of the study, participants are randomly assigned to take either 1,300 mg. (two capsules) of the Nature's Pearl Muscadine Grape Seed Supplement (grape seeds) daily or a placebo (inactive capsule).

For further details of the clinical trial design, see the Science Daily report. Patients have already been recruited and results are expected to be analyzed in early 2008.

Permalink: Muscadine Grapeseed Supplement on Clinical Trial for CArdiovascular Disease

Tags: dietary+supplement  resveratrol  heart+disease  athersclerosis  cardiovascular+disease  grapeseed  polyphe 

Vote for Muscadine Grapeseed Supplement on Clinical Trial for CArdiovascular Disease:

  • Currently 7.00/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 7.00 out of 5 vote(s) cast.
 
Share It
RSSrss
Google google
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Most Popular   Best of   Biotech Hubs and Facilities   Biotech/Science Blogs   Corporate and Industrial News   Diagnostics, Methodologies and Instrumentation   Did you know   Drugs, Vaccines and Therapeutics   Energy, Environment and Ecology   Food and Agriculture   Gene Therapy   Genomics, Proteomics and Bioinformatics   Information About   Meetings and Other Events   Microbiology   Misc   Nanomedicine   Other Biotechnology News   Patents and Intellectual Property Rights   Quick introduction   Stem Cells